Dietary Inflammatory Index MASLD Liver Fibrosis Fatty Liver
Dietary Inflammatory Index Falls Short in Predicting MASLD Severity
New research suggests that broad systemic inflammatory indices may not accurately reflect the nuances of metabolic dysfunction-associated steatotic liver disease (MASLD).
A recent study has cast doubt on the utility of the Dietary Inflammatory Index (DII) and the Systemic Immune-Inflammation Index (SII) as reliable indicators for assessing the severity of MASLD. The findings highlight potential limitations in using these generalized systemic inflammatory markers to evaluate organ-specific conditions,suggesting a need for more targeted approaches in understanding and managing the disease.
DII and SII: Limited Predictive Power in MASLD
The study found that neither the DII nor the SII demonstrated a meaningful association with key indicators of liver disease severity in patients with MASLD. This suggests that while these indices might offer insights into general inflammation, they may not capture the specific pathological processes driving MASLD progression.
Researchers pointed out that the DII, which relies on a static, short-term dietary recall, may not adequately represent the chronic and cumulative dietary exposures that contribute to liver damage over time. This “temporal mismatch” between how dietary exposure is assessed and how the disease evolves could weaken its prognostic value.
The authors proposed that the pathophysiology of MASLD might involve a shift from inflammation-driven injury to metabolic toxicity-driven progression, similar to trends observed in type 2 diabetes. in type 2 diabetes, early insulin resistance can lead to beta-cell dysfunction, ultimately resulting in beta-cell apoptosis, dedifferentiation, and functional exhaustion. Similarly, in MASLD, early stages might be dominated by gut-derived inflammation, but as the disease progresses, hepatocyte lipotoxicity and stellate cell activation become the primary drivers of fibrosis and steatosis. In this context, generalized systemic markers may lose their predictive value.
Nutrient-Specific Effects Matter
Another significant limitation of the DII identified by the researchers is its inability to account for the distinct biological effects of specific nutrients. For example, omega-3 fatty acids are known to possibly reduce hepatic fibrogenesis by inhibiting the NF-κB pathway and decreasing oxidative stress. Conversely, fructose and saturated fats can directly promote lipogenesis and damage hepatocytes. By aggregating these diverse effects into a single score, the DII may obscure crucial mechanistic differences that are vital for understanding MASLD.
“This heterogeneity in nutrient-specific effects underscores the need to move beyond generalized inflammatory scores and toward mechanistic dissection of diet-liver interactions at the molecular level,” the authors stated. They emphasized that such insights are essential for developing targeted and effective nutritional interventions for MASLD.
References
- Sang Z, Wang H, leng Y, et al. association of dietary inflammatory index with liver fibrosis and fatty liver index in a population with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study. Front Nutr. 2025; 12: 1594192. doi: 10.3389/fnut.2025.1594192
- Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne). 2013; 4: 37. DOI: 10.3389/Fendo.2013.00037